Filing Details
- Accession Number:
- 0001209191-21-060895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-19 16:15:15
- Reporting Period:
- 2021-10-15
- Accepted Time:
- 2021-10-19 16:15:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1828443 | Ortho Clinical Diagnostics Holdings Plc | OCDX | In Vitro & In Vivo Diagnostic Substances (2835) | 981151819 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1839441 | A. Michael Schlesinger | C/O Ortho Clinical Diagnostics Holdings 1001 Route 202 Raritan NJ 08869 | Evp, Gc And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, $0.00001 Par Value | Acquisiton | 2021-10-15 | 75,464 | $6.28 | 163,101 | No | 4 | M | Direct | |
| Ordinary Shares, $0.00001 Par Value | Disposition | 2021-10-15 | 75,464 | $19.73 | 87,637 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares, $0.00001 Par Value | Stock Option | Disposition | 2021-10-15 | 75,464 | $0.00 | 75,464 | $6.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 218,043 | 2024-10-22 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
- Represents the weighted average sales price for the price increments ranging from $19.5900 to $19.9200.
- The stock option is fully vested and exercisable.
Billionaire Hedge Funds
